Germán Velásquez

881 total citations
25 papers, 378 citations indexed

About

Germán Velásquez is a scholar working on Economics and Econometrics, Sociology and Political Science and Management of Technology and Innovation. According to data from OpenAlex, Germán Velásquez has authored 25 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 4 papers in Sociology and Political Science and 4 papers in Management of Technology and Innovation. Recurrent topics in Germán Velásquez's work include Pharmaceutical Economics and Policy (13 papers), Intellectual Property and Patents (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Germán Velásquez is often cited by papers focused on Pharmaceutical Economics and Policy (13 papers), Intellectual Property and Patents (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Germán Velásquez collaborates with scholars based in Switzerland, Brazil and Cuba. Germán Velásquez's co-authors include Jonathan D. Quick, Hans V. Hogerzeil, Lembit Rägo, Félix Lobo, Sara Bennett, Jorge Antônio Zepeda Bermudez, Gabriela Costa Chaves, Maria Auxiliadora Oliveira, Andrew Cassels and Eric Goosby and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Public Health Policy.

In The Last Decade

Germán Velásquez

20 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Germán Velásquez Switzerland	9	160	77	68	65	62	25	378
Jacqui Miot South Africa	13	205 1.3×	90 1.2×	124 1.8×	134 2.1×	76 1.2×	50	540
Tomasz Bochenek Poland	10	200 1.3×	53 0.7×	38 0.6×	65 1.0×	75 1.2×	28	366
Edmund Rutta United States	14	126 0.8×	171 2.2×	82 1.2×	120 1.8×	134 2.2×	19	441
Noel Juban Philippines	11	39 0.2×	50 0.6×	83 1.2×	63 1.0×	79 1.3×	30	422
Sauwakon Ratanawijitrasin Thailand	8	148 0.9×	81 1.1×	61 0.9×	59 0.9×	79 1.3×	19	306
Jafary Liana United States	9	112 0.7×	150 1.9×	60 0.9×	101 1.6×	118 1.9×	11	313
Lamphone Syhakhang Sweden	12	208 1.3×	116 1.5×	65 1.0×	216 3.3×	153 2.5×	16	463
Mary Couper Switzerland	8	133 0.8×	113 1.5×	22 0.3×	77 1.2×	46 0.7×	9	451
Unni Gopinathan Norway	13	130 0.8×	92 1.2×	100 1.5×	76 1.2×	137 2.2×	47	475
Hanne Bak Pedersen Denmark	11	318 2.0×	95 1.2×	98 1.4×	54 0.8×	210 3.4×	24	718

Countries citing papers authored by Germán Velásquez

Since Specialization

Citations

This map shows the geographic impact of Germán Velásquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Germán Velásquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Germán Velásquez more than expected).

Fields of papers citing papers by Germán Velásquez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Germán Velásquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Germán Velásquez. The network helps show where Germán Velásquez may publish in the future.

Co-authorship network of co-authors of Germán Velásquez

This figure shows the co-authorship network connecting the top 25 collaborators of Germán Velásquez. A scholar is included among the top collaborators of Germán Velásquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Germán Velásquez. Germán Velásquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torreele, Els, Olusoji Adeyi, Mandeep Dhaliwal, et al.. (2023). It is time for ambitious, transformational change to the epidemic countermeasures ecosystem. The Lancet. 401(10381). 978–982. 19 indexed citations

Velásquez, Germán. (2022). Vaccines, Medicines and COVID-19. OAPEN (The OAPEN Foundation). 4 indexed citations

Velásquez, Germán. (2021). Vacunas COVID-19: el inmoral comercio de bienes públicos. ¿Y cuál es el papel de la OMS?. SHILAP Revista de lepidopterología. 39(2). 1–3. 1 indexed citations

Correa, Carlos M. & Germán Velásquez. (2019). Access to Medicines: Experiences with Compulsory Licenses and Government Use - The Case of Hepatitis C. SSRN Electronic Journal. 3 indexed citations

Velásquez, Germán, et al.. (2019). Construcción de un visor cartográfico para la administración de información técnica georreferenciada y el seguimiento contractual de activos en exploración y producción de hidrocarburos.

Velásquez, Germán. (2019). Medicines and Intellectual Property: 10 Years of the WHO Global Strategy. SSRN Electronic Journal. 3 indexed citations

Velásquez, Germán. (2018). Pautas de patentabilidad y acceso a medicamentos. 45–92. 2 indexed citations

Sridhar, Devi, Ngaire Woods, Mark Dybul, et al.. (2018). Global governance of antimicrobial resistance. The Lancet. 391(10134). 1976–1978. 82 indexed citations

Velásquez, Germán. (2016). ¿Qué remedios para la OMS?: una organización a la deriva. 17. 1 indexed citations

10.

Velásquez, Germán. (2014). The Right to Health and Medicines: The Case of Recent Multilateral Negotiations on Public Health, Innovation and Intellectual Property. Developing World Bioethics. 14(2). 67–74. 9 indexed citations

11.

Muñoz, Viviana, et al.. (2013). Financial resources for implementation of tobacco control measures : potential of innovative financing.

12.

Velásquez, Germán. (2011). El acceso global a los medicamentos en el contexto internacional actual. Biomédica. 31(2). 161–161. 1 indexed citations

13.

Oliveira, Maria Auxiliadora, Jorge Antônio Zepeda Bermudez, Gabriela Costa Chaves, & Germán Velásquez. (2004). Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?. SHILAP Revista de lepidopterología. 82(11). 815–21. 47 indexed citations

14.

Quick, Jonathan D., Hans V. Hogerzeil, Germán Velásquez, & Lembit Rägo. (2002). Twenty-five years of essential medicines.. SHILAP Revista de lepidopterología. 80(11). 913–4. 91 indexed citations

15.

Lobo, Félix, et al.. (2002). Medicines and the New Economic Environment. Journal of Public Health Policy. 23(2). 245–245.

16.

Velásquez, Germán. (1999). Farmacoeconomía: ¿evaluación científica o estrategia comercial?. Revista Panamericana de Salud Pública. 5(1). 54–7. 15 indexed citations

17.

Velásquez, Germán, et al.. (1999). Essential drugs in the new international economic environment.. PubMed. 77(3). 288–92. 8 indexed citations

18.

Velásquez, Germán, et al.. (1998). The economics of pharmaceuticals and health sector reform in the Americas. Revista Panamericana de Salud Pública. 3(5). 343–350. 3 indexed citations

19.

Velásquez, Germán. (1989). Médicaments et financement des systèmes de santé dans les pays du Tiers Monde. Tiers-Monde. 30(118). 455–463. 1 indexed citations

20.

Velásquez, Germán. (1983). L'industrie du médicament et le Tiers Monde. Medical Entomology and Zoology. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact